The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma

Cell Death Dis. 2022 Mar 4;13(3):210. doi: 10.1038/s41419-022-04637-8.

Abstract

It is urgent to identify and validate biomarkers for early diagnosis and efficient treatment of nasopharyngeal carcinoma (NPC). Recent studies have proposed p38 gamma (p38γ) as a cyclin-dependent kinase (CDK)-like kinase that phosphorylates retinoblastoma (Rb) to promote cyclins expression and tumorigenesis. Here the Gene Expression Profiling Interactive Analysis (GEPIA) database and results from the local NPC tissues demonstrate that p38γ is significantly upregulated in NPC tissues, correlating with poor overall survival. Furthermore, p38γ mRNA and protein expression is elevated in established NPC cell lines (CNE-1 HONE-1 and CNE-2) and primary human NPC cells, but low expression detected in human nasal epithelial cells. In established and primary NPC cells, p38γ depletion, using the shRNA strategy or the CRISPR/Cas9 gene-editing method, largely inhibited cell growth, proliferation and migration, and induced significant apoptosis activation. Contrarily, ectopic p38γ overexpression exerted opposite activity and promoted NPC cell proliferation and migration. Retinoblastoma (Rb) phosphorylation and cyclin E1/A expression were decreased in NPC cells with p38γ silencing or knockout, but increased after p38γ overexpression. Moreover, mitochondrial subcellular p38γ localization was detected in NPC cells. Significantly, p38γ depletion disrupted mitochondrial functions, causing mitochondrial depolarization, reactive oxygen species production, oxidative injury and ATP depletion in NPC cells. In vivo, intratumoral injection of adeno-associated virus-packed p38γ shRNA potently inhibited primary human NPC xenograft growth in nude mice. In p38γ shRNA virus-injected NPC xenograft tissues, p38γ expression, Rb phosphorylation, cyclin E1/A expression and ATP levels were dramatically decreased. Taken together, we conclude that p38γ overexpression is required for NPC cell growth, acting as a promising therapeutic target of NPC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate
  • Animals
  • Carcinogenesis
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Cyclins
  • Humans
  • Mice
  • Mice, Nude
  • Mitogen-Activated Protein Kinase 12
  • Nasopharyngeal Carcinoma / drug therapy
  • Nasopharyngeal Carcinoma / genetics
  • Nasopharyngeal Neoplasms* / pathology
  • RNA, Small Interfering / therapeutic use
  • Retinal Neoplasms*
  • Retinoblastoma*

Substances

  • Cyclins
  • RNA, Small Interfering
  • Adenosine Triphosphate
  • Mitogen-Activated Protein Kinase 12